SAN CLEMENTE, Calif.–(BUSINESS WIRE)— Reflow Medical, Inc., a developer and innovator of crossing and support catheters for use in the treatment of occlusive cardiovascular disease, announced that the company has…

San Clemente, Calif.–(BUSINESS WIRE)—ReFlow Medical Inc. announced the issuance of U.S. Patent No. 9,204,893 entitled, “Systems, Methods, and Devices for Ablation, Crossing, and Cutting of Occlusions” for its innovative Wingman...

SAN CLEMENTE, Calif.–(BUSINESS WIRE)—ReFlow Medical, Inc. (ReFlow) today announced FDA clearance for US commercialization of their speX™ Shapeable Support Catheter for use in the peripheral vasculature as well as the first...

(L) John R. Laird, Jr., MD, is an Interventional Cardiology and Cardiology specialist in St. Helena, CA. (R) Mahmood K. Razavi, MD, specializes in Radiology, Vascular and Interventional Radiology in...

SAN CLEMENTE, Calif.–(BUSINESS WIRE)—ReFlow Medical, Inc. (ReFlow) today announced the initial clinical use of their Wingman35 Crossing Catheter and speX™ Shapeable Support Catheter by Dr. Andrej Schmidt at University Leipzig, Germany….

ReFlow Medical, Inc. today announced that it has signed an exclusive distribution and sales agreement for ReFlow’s suite of peripheral chronic total occlusion (CTO) products with MicroPort Endovascular (MicroPort Endo),...